View our 5 key takeaways from this discussion.
As the COVID-19 pandemic nears its third anniversary, what is the state of vaccination among adults in the United States?
Rapid development and deployment of COVID-19 vaccines has saved hundreds of thousands of lives in the U.S. and greatly reduced serious illness. Yet uptake of COVID-19 boosters has lagged. Meanwhile, millions of U.S. adults have missed routine, non-COVID vaccinations since the onset of COVID-19, exposing them to the risk of vaccine-preventable diseases.
Promising developments in adult vaccination include the elimination of patient co-pays for vaccinations covered by the Medicare prescription drug program. Novel vaccines will likely be introduced in the months ahead that protect against diseases for which no vaccine exists today, and new vaccine combinations could make vaccination more convenient for patients. But the U.S. continues to face an urgent need to restore and improve vaccination rates across all CDC-recommended vaccines, and to prepare for future pandemic threats.
Join us to explore the state of adult vaccination in the U.S. through the new web-based Vaccine Track program, and prospects for raising vaccination rates among Medicare beneficiaries and other U.S. adults. Our panel includes:
- Abby Bownas: Co-Manager, Adult Vaccine Access Coalition
- Kathryn Hashey, MA, MPH: Director of Vaccine Policy, GSK
- Sean Gallagher: Senior Principal, IQVIA
- Jewel Mullen, MD: Associate Dean for Health Equity and Associate Professor of Population Health and Internal Medicine, University of Texas Dell Medical School; Member, National Vaccine Advisory Committee
